The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Significant condition. by Junxia Zhou (14381598)

Subjects:

Networks favouring more connected individuals results in a significant decrease to the likelihood of network recovery. by Adam Lee Miles (14123916)

Results of significance for regression factors. by Junxia Zhou (14381598)

Subjects:

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

Subjects:

Why does task performance decrease with burst length? by Swathi Anil (17382903)

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Graphical presentation of % decrease for insulin from baseline at different conditions. by Nathan Mubiru (21627195)

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Significant gene set results from EGSEA. by Katherine M. Peterson (19746455)

“…<p>The significant gene sets returned by EGSEA analysis of serum-deprived ARPE-19 cell differentially expressed genes. …”

STL Linear Combination Forecast Graph. by Xiangjuan Liu (618000)

“…Further integration of Spearman correlation analysis and PCA dimensionality reduction created multidimensional feature sets, revealing substantial accuracy improvements: The BiLSTM model achieved an 83.6% cumulative MAE reduction from 1.65 (raw data) to 0.27 (STL-PCA), while traditional models like Prophet showed an 82.2% MAE decrease after feature engineering optimization. …”

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Linear regression. by Myriam Aïche (22290591)

Subjects: